-+ 0.00%
-+ 0.00%
-+ 0.00%

Versigent Q3 2026 attributable net income falls 6% to $102 million; Q3 2026 net sales rise 7% to $2.45 billion

PUBT·11/04/2026 11:37:10
Versigent Q3 2026 attributable net income falls 6% to $102 million; Q3 2026 net sales rise 7% to $2.45 billion
  • Versigent’s third-quarter 2026 net income attributable to shareholders fell 6% year-over-year to $102 million.
  • Net sales rose 7% year-over-year to $2.45 billion.
  • Capital expenditures climbed 25% year-over-year to $55 million, reflecting higher launch activity in the second half of 2026.
  • The business secured $2.1 billion of bookings during the quarter.
  • Full-year 2026 net sales guidance narrowed to $9.5 billion–$9.6 billion, with a higher midpoint due to higher commodity pass-throughs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Versigent plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202611040630BIZWIRE_USPR_____20261104_BW338360) on November 04, 2026, and is solely responsible for the information contained therein.